| Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma (NCT04459078) | Hunan Cancer Hospital | 2020-08-26 |
| Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung (NCT02466568) | H. Lee Moffitt Cancer Center and Research Institute | 2018-07-01 |
| Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology (NCT04046614) | AIO-Studien-gGmbH | 2018-05-25 |
| Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor (NCT03041181) | Nasser Hanna, M.D. | 2017-01-27 |
| Circulating Tumor DNA in Patients at High Risk for Lung Cancer (NCT02715102) | Pathway Genomics | 2016-06-01 |
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation (NCT02264210) | Sun Yat-sen University | 2015-01-01 |
| Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer (NCT02288026) | Capital Medical University | 2014-09-01 |
| S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib (NCT02134912) | SWOG Cancer Research Network | 2014-08-01 |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC (NCT02059967) | Virginia Commonwealth University | 2014-03-01 |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers (NCT01935336) | University of Colorado, Denver | 2013-09-24 |
| Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer (NCT01707823) | Vanderbilt-Ingram Cancer Center | 2012-10-01 |
| Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung (NCT01561456) | Axelar AB | 2011-12-01 |
| A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung (NCT01218516) | Morphotek | 2011-06-27 |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NCT01259089) | Northwestern University | 2011-04-27 |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT01345851) | Jonsson Comprehensive Cancer Center | 2011-03-23 |
| Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) (NCT00511485) | Endocyte | 2007-08-01 |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959) | Wake Forest University Health Sciences | 2007-07-01 |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00368992) | National Cancer Institute (NCI) | 2006-08-01 |
| Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00118183) | National Cancer Institute (NCI) | 2005-07-01 |
| Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer (NCT00118144) | National Cancer Institute (NCI) | 2005-06-01 |
| S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer (NCT00087412) | National Cancer Institute (NCI) | 2004-09-01 |
| Photodynamic Therapy in Treating Patients With Lung Cancer (NCT01668823) | Roswell Park Cancer Institute | 2004-02-01 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery (NCT00049543) | National Cancer Institute (NCI) | 2002-09-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer (NCT00021060) | National Cancer Institute (NCI) | 2002-08-01 |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00040794) | National Cancer Institute (NCI) | 2002-05-01 |
| Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00020709) | National Cancer Institute (NCI) | 2001-06-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00005838) | National Cancer Institute (NCI) | 2000-03-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer (NCT00002852) | National Cancer Institute (NCI) | 1996-10-01 |